Skip to main content
Premium Trial:

Request an Annual Quote

Getting Closer, But Work Remains

Premium

While progress is being made toward the goal of personalized medicine for cancer patients, much work remains, writes Rachael Rettner at MyHealthNewsDaily. "We're much better than we were a decade ago" at tailoring patients' treatments, Monter Cancer Center's Daniel Budman tells Rettner. Much of this progress is being fueled by advances in genome sequencing — which is falling quickly in price — as sequencing can be used to find the mutations in a particular patient's tumor. Marc Symons from the Feinstein Institute for Medical Research adds that the main hurdle is determining which mutations affect the course of the disease and finding drugs that target those mutations.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.